Bristol Myers Squibb stock pre-market at EUR 52.64: plus 0.42 percent
Published on 10/06/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol Myers Squibb stock is at EUR 52.64 pre-market at 8:26 a.m. CEST on October 6, 2026. The price is up 0.42 percent versus the Lang & Schwarz prior close of EUR 52.42 on October 5, 2026.
Pre-market price
Lang & Schwarz shows a bid of EUR 52.44 and an ask of EUR 52.83. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.
Recent company announcements
Bristol Myers Squibb’s investor-relations page lists an October 1, 2026 announcement on deepening its commitment to healthcare professionals through the Champions in Care movement. The same page lists a September 30, 2026 U.S. Food and Drug Administration approval of an expanded indication for CAMZYOS and a September 25, 2026 announcement on the first presentation of ZENBEXUS results in combination with daratumumab from the Phase 3 EXCALIBER-RRMM trial. Bristol Myers Squibb investor relations lists the announcements and dates.
